Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)
CAPS Rating:
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
Pancreatic cancer is hard to show survival. Refractory pancreatic cancer is impossible to survival.